Standard short-term diet ameliorates the lipid profile altered by a fructose-rich diet in rats

Journal of Developmental Origins of Health and Disease

Volumn 6, Issue 4, 2015, Pages 335-341

  Cambri, L T ^a,b   Ghezzi, A C ^b   Arsa, G ^a   Botezelli, J D ^b   De Mello, M A R ^b  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

body weight; fructose rich diet; lipid profile; metabolic syndrome; standard diet

Indexed keywords

FRUCTOSE;

ANIMAL; DIET THERAPY; DYSLIPIDEMIAS; FEMALE; MALE; OBESITY; PREGNANCY; WISTAR RAT;

ADIPOSITY; ANIMALS; DYSLIPIDEMIAS; FEMALE; FRUCTOSE; MALE; PREGNANCY; RATS, WISTAR;

EID: 84935138812     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174415001026     Document Type: Article

References (39)

1. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diabetologia. 2005; 48, 1684-1699.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002; 287, 356-359.
3. Mohan V, Deepa M. The metabolic syndrome in developing countries. Diabetes Voice. 2006; 51(special issue), 1-3.
4. Gupta N, Shah P, Nayyar S, Misra A. Childhood obesity and the metabolic syndrome in developing countries. Indian J Pediatr. 2013; 80, 28-37.
5. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, 2006. International Diabetes Federation.
6. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002; 76, 911-922.
7. Dhingra R, Sullivan L, Jacques PF, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007; 116, 480-488.
8. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol. 2005; 1, 80-86.
9. Basciano H, Federico L, Khosrow A. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr & Metabol. 2005; 2, 5.
10. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987; 10, 512-516.
11. Botezelli JD, Mora RF, Dalia RA, et al. Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. Lipids Health Dis. 2010; 9, 116.
12. Botezelli JD, Cambri LT, Ghezzi AC, et al. Fructose-rich diet consumption leads to reduced aerobic capacity and to liver injury in rats. Lipids Health Dis. 2012; 11, 78.
13. Cambri LT, Ghezzi AC, Ribeiro C, Dalia RA, Mello MAR. Recovery of rat growth and lipid profiles in adult rats subjected to fetal protein malnutrition with a fructose-rich diet. Nut Res. 2010; 30, 156-162.
14. Cambri LT, De Araujo GG, Ghezzi AC, Botezelli JD, Mello MAR. Metabolic responses to acute physical exercise in young rats recovered from fetal protein malnutrition with a fructoserich diet. Lipids Health Dis. 2011; 10, 164.
15. Ghezzi A, Cambri LT, Ribeiro C, Botezelli JD, Mello MAR. Impact of early fructose intake on metabolic profile and aerobic capacity of rats. Lipids Health Dis. 2011; 10, 3.
16. Ghezzi A, Cambri LT, Ribeiro C, Botezelli JD, Mello MAR. Metabolic syndrome in rats at different ages. Diabetol Metabol Syndr. 2012; 4, 16.
17. Douard V, Ferraris RP. Regulation of the fructose transporter Glut5 in health and disease. Am J Physiol Endocrinol Metab. 2008; 295, E227-E237.
18. Jones HF, Burt E, Dowling K, et al. Effect of age on fructose malabsorption in children presenting with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2011; 52, 581-584.
19. Girard A, Madani S, Boukortt F, et al. Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats. Nutrition. 2006; 22, 758-766.
20. Jürgens H, Haass W, Castañeda TR, et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res. 2005; 13, 1146-1156.
21. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988; 37, 1595-1607.
22. Sanchez-Lozada LG, Tapia E, Jimenez A, et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. AJP - Renal Physiol. 2007; 292, F423-F429.
23. Reeves PG, Nielsen FH, Fahey-JR GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of AIN-76: a rodent diet. J Nutr. 1993; 123, 1939-1951.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18, 499-502.
25. Cinti S. The adipose organ. Prostaglendins, Leukotrienes and Essential Fatty Acids. 2005; 73, 9-15.
26. Nogueira DM, Strufaldi B, Hirata MH, Abdalla DSP, Hirata RDC. Sangue - parte I: glicídios (blood - part 1: glycides). In Métodos De Bioquímica Clínica (Methods of Clinical Biochemistry) (eds. Nogueira DM, Strufaldi B, Hirata MH, Abdalla DS and Hirata RDC), 1990; pp. 153-168. Pancast: São Paulo.
27. Dubois B, Gilles KA, Hamilton JK, Rebers PA. Colorimetric method for determination of sugar and relate substances. Anal Chem. 1956; 28, 350-356.
28. Douard V, Choi H, Elshenawy S, Lagunoff D, Ferraris RP. Developmental reprogramming of rat Glut5 requires glucocorticoid receptor translocation to the nucleus. Physiol. 2008; 586(Pt. 15), 3657-3673.
29. Barone S, Fussell SL, Singh AK, et al. Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem. 2009; 284, 5056-5066.
30. Joyeux-Faure M, Rossini E, Ribuot C, Faure P. Fructose-fed rat hearts are protected against ischemia-reperfusion injury. Exp Biol Med. 2006; 231, 456-462.
31. Roglans R, Vila L, Farré M, et al. Impairment of hepatic stat-3 activation and reduction of PPAR- activity in fructose-fed rats. Hepatology. 2007; 45, 778-788.
32. Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology. 2004; 145, 548-555.
33. Sharabi Y, Oron-Herman M, Kamari Y, et al. Effect of PPAR-γ agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hypertension. 2007; 20, 206-210.
34. Rajasekar P, Anuradha CV. Fructose-induced hepatic gluconeogenesis: effect of L-carnitine. Life Sci. 2007; 80, 1176-1183.
35. Williams PT. High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med. 1996; 334, 1298-1303.
36. Siervogel RM, Wisemandle W, Maynard LM, et al. Serial changes in body composition throughout adulthood and their relationship to changes in lipid and lipoprotein levels. Arterioscler Thromb Vasc Biol. 1998; 18, 1759-1764.
37. Krauss RM. Lipids and lipoproteins in patients whit type 2 diabetes. Diabetes Care. 2004; 27, 1496-1504.
38. Dâmaso A. Nutrição E Exercício Na Prevenção De Doenças, 2001. Medsi: Rio de Janeiro.
39. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc. 2001; 33, S502-S515.